Vol. 20, Issue 2, 2013January 01, 2013 EDT
A Pharmaceutical Park Place: Why the Supreme Court Should Modify the Scope of the Patent Test for Reverse Payment Deals
A Pharmaceutical Park Place: Why the Supreme Court Should Modify the Scope of the Patent Test for Reverse Payment Deals
David Ernest Balajthy,
patentreverse paymentpharmaceuticalspay-for-delayIn re Tamoxifen Antitrust Litigationscope-of-the-patent testFederal Trade CommissionDrug Price Competition and Patent Term Restoration Act of 1984Hatch-Waxman ActFDAANDAprimary patentssecondary patentsTamoxifenZeneca
David Ernest Balajthy, A Pharmaceutical Park Place: Why the Supreme Court Should Modify the Scope of the Patent Test for Reverse Payment Deals, 20 Journal of Intellectual Property 315 (2013).